Article

Iinvezz.com on 2021-07-16 16:28

Here’s why three hospitals are refusing to treat patients with Biogen’s new Alzheimer’s drug

Here’s why Goldman Sachs is ‘flattish’ on SPX for the second half of 2021. The benchmark S&P 500 index to gradually start climbing again in 2022.

Related news

Biogen’s New Alzheimer’s Drug Beyond Reach for Many Patients wsj.com
Providence
BAnother Setback for Biogen’s Controversial Alzheimer’s Drug1 min read barrons.com
New York
IDr. Karlawish on Biogen’s Alzheimer’s drug approval: ‘another study is needed’invezz.com
Canada
The harrowing new reality for Alzheimer’s patients vox.com
Massachusetts , Cambridge , Oregon
U.S. approves Eisai and Biogen’s drug to slow Alzheimer’s disease The Japan Times
Utah , Americas , New York , Cambridge , United States
Biogen’s controversial Alzheimer’s drug made $1.6M in revenue in June New York Post
Rhode Island , Wall Street
Biogen’s $56 000 Alzheimer’s drug evades Biden’s cost curbs pressherald.com
Vermont
An Alabama doctor watched patients reject coronavirus vaccine; now he’s refusing to treat them Seattle Times
United States , Alabama
Sick of watching patients reject the COVID vaccine, a US doctor is refusing to treat them Sydney Morning Herald
Nashville , Tennessee , United States , Alabama
An Alabama doctor watched patients reject the coronavirus vaccine. Now he’s refusing to treat them.Alaska Dispatch News
United States , Alabama
Biogen’s Alzheimer’s Drug Won’t Be Covered by VA Health System wsj.com
Veterans Affairs
Rural hospitals treat record numbers of COVID patients - Sat, 09 Oct 2021 PST The Spokesman-Review
Spokane , Americas , Whitman , Newport Hospital , Portland
Texas sends drug remdesivir to Dallas-Fort Worth hospitals to treat COVID-19 patients Star Telegram
California , United States , Dallas , Parkland Memorial Hospital , Fort Worth
Next Billion-Dollar Startups: How Viz.ai Helps Hospitals Treat Stroke Patients Earlier (Video)Forbes
Mount Sinai , Israel
CMS Expands Regulatory Flexibilities to Allow Qualified Hospitals to Treat Certain Patients at Home jdsupra.com
Alzheimer’s drug may benefit some patients, new data shows staradvertiser.com
United States , San Francisco
MHow NYC hospitals have become better equipped to treat COVID-19 patients marketwatch.com
Kips Bay , Louisiana , New York
What’s Behind Biogen’s Move To Cut Prices On Its Controversial Alzheimer’s Drug Aduhelm?Forbes
Florida , Phase 4
MBiogen’s FDA-approved Alzheimer’s drug, first new remedy in almost twenty years mvtelegraph.com
Wall Street , United States
FDA approves Biogen’s Alzheimer’s drug, the first to slow the disease wsj.com